Regeneron doubles down on CytomX after other pharmas walked away

Sean McCarthy, CytomX CEO June 3, 2026 10:56 AM EDT DealsPharma Re­gen­eron dou­bles down on Cy­tomX af­ter oth­er phar­mas walked away Kyle LaHucik Biotech Correspondent Af­ter los­ing a cou­ple of phar­ma al­liances in re­cent quar­ters, Cy­tomX Ther­a­peu­tics is get­ting a ma­jor lift from a key col­lab­o­ra­tor. Re­gen­eron is dou­bling down … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER